Alcohol and gynaecomastia are more closely linked than many men realise. Chronic or heavy alcohol use can disrupt the balance between oestrogen and testosterone, creating a hormonal environment that promotes the growth of glandular breast tissue in males. This article explains how alcohol affects hormone levels, its role as a recognised risk factor for gynaecomastia, other common causes of the condition, when to seek GP advice, and what diagnosis and treatment options are available on the NHS — including practical steps to reduce alcohol intake and support recovery.

How Alcohol Affects Hormone Levels in Men

Alcohol reduces testosterone by damaging Leydig cells, impairs oestrogen metabolism in the liver, and may increase aromatase activity, collectively raising oestrogen relative to testosterone — particularly with chronic heavy use.

Have any more questions about this? Message our pharmaceutical team to get more info →

Alcohol has a well-documented effect on the endocrine system, particularly on the hormones that regulate male reproductive health. When consumed regularly or in excess, alcohol can disrupt the delicate balance between oestrogen and testosterone — the two key hormones involved in determining male physical characteristics, including breast tissue development.

Alcohol interferes with hormone regulation through several mechanisms:

• Reduced testosterone production: Alcohol is directly toxic to Leydig cells in the testes, which are responsible for producing testosterone. Chronic heavy alcohol use can significantly lower circulating testosterone levels.

• Increased oestrogen activity: The liver plays a central role in metabolising oestrogen. Heavy drinking impairs liver function, reducing its ability to break down oestrogen efficiently, which can lead to elevated oestrogen levels in the bloodstream. This effect is most pronounced in men with alcohol-related liver disease.

• Elevated aromatase activity: In the context of chronic heavy alcohol use, obesity, or liver disease, alcohol may increase the activity of aromatase — an enzyme that converts androgens (male hormones) into oestrogens — further shifting the hormonal balance.

Alcohol may also affect sex hormone-binding globulin (SHBG), which binds to free testosterone and reduces its availability; however, this effect is most clinically relevant in the setting of sustained heavy use and liver impairment rather than moderate drinking.

The net result of these combined effects — particularly with long-term heavy consumption — is a relative increase in oestrogen compared to testosterone: a hormonal environment that can promote the growth of glandular breast tissue in men. It is important to note that occasional or moderate drinking is far less likely to cause clinically significant hormonal disruption than sustained heavy use. Understanding these mechanisms provides important context for exploring whether alcohol can directly contribute to gynaecomastia.

Sources: NICE CKS: Gynaecomastia; NHS: Gynaecomastia (enlarged male breasts).

The Link Between Alcohol and Gynaecomastia

Alcohol misuse, especially when associated with liver disease, is a recognised risk factor for gynaecomastia, as elevated oestrogen levels stimulate glandular breast tissue growth in men.

Gynaecomastia refers to the benign enlargement of glandular breast tissue in males, caused by an imbalance between oestrogen and androgen activity. Given alcohol's known effects on hormone levels, it is reasonable to ask whether drinking can cause or contribute to this condition — and the evidence suggests it can, particularly in cases of chronic or heavy alcohol use.

Alcohol misuse, particularly when associated with alcohol-related liver disease, is a recognised risk factor for gynaecomastia. Men with liver cirrhosis are especially susceptible: cirrhosis impairs the liver's ability to metabolise oestrogens, leading to persistently elevated oestrogen levels that can stimulate the proliferation of glandular breast tissue over time.

It is important to distinguish between true gynaecomastia (involving actual glandular tissue) and pseudogynaecomastia (caused by excess fatty tissue in the chest area, often associated with obesity). Alcohol contributes to both: it is calorie-dense and can promote weight gain, which may cause pseudogynaecomastia, while its hormonal effects can trigger true gynaecomastia. Weight loss can help reduce pseudogynaecomastia.

That said, not every man who drinks alcohol will develop gynaecomastia. Individual susceptibility varies depending on genetic factors, overall health, the presence of liver disease, and the quantity and duration of alcohol consumption. Occasional or moderate drinking is far less likely to cause significant hormonal disruption than long-term heavy use. Nevertheless, alcohol misuse remains a recognised and sometimes overlooked lifestyle contributor to this condition.

Sources: NICE CKS: Gynaecomastia; NHS: Gynaecomastia (enlarged male breasts).

Other Common Causes of Gynaecomastia

Gynaecomastia has many causes beyond alcohol, including physiological changes at puberty and older age, medications such as spironolactone and finasteride, and medical conditions including hypogonadism and hyperthyroidism.

While alcohol can contribute to gynaecomastia, this condition has many potential causes, and a thorough clinical assessment is always necessary to identify the underlying reason.

Physiological causes are among the most common:

• Neonatal gynaecomastia occurs in newborns due to maternal oestrogen exposure and typically resolves within weeks.

• Pubertal gynaecomastia affects around 60% of adolescent boys and usually resolves spontaneously within one to two years.

• Age-related gynaecomastia is common in older men due to declining testosterone levels and increased body fat, which raises aromatase activity.

Medications are a significant and frequently underappreciated cause. Drugs with well-established associations with gynaecomastia include:

• Spironolactone and other anti-androgens (e.g., bicalutamide)

• Finasteride and dutasteride (5-alpha reductase inhibitors)

• Cimetidine (an H2-receptor antagonist)

• Anabolic steroids

• Certain antipsychotics, particularly risperidone (via hyperprolactinaemia)

• Certain antihypertensives and chemotherapy agents

Some antidepressants have been associated with gynaecomastia, though this is uncommon and varies by agent. If you are concerned about a medicine you have been prescribed, speak to your GP before making any changes — do not stop a prescribed medicine without medical advice.

Medical conditions that can cause gynaecomastia include hypogonadism, hyperthyroidism, hyperprolactinaemia, chronic kidney disease, malnutrition, and testicular or adrenal tumours that secrete hormones. Klinefelter syndrome, a chromosomal condition, is also associated with an increased risk. Some antiretroviral medicines used in HIV treatment have also been linked to gynaecomastia.

Recreational drugs, including cannabis (though evidence is variable) and heroin, have also been associated with gynaecomastia. It is worth noting that in a proportion of cases — estimated at around 25% — no clear cause is identified, and the condition is classified as idiopathic. A GP will consider all of these possibilities before attributing gynaecomastia to any single factor such as alcohol.

Sources: NICE CKS: Gynaecomastia; BNF entries for spironolactone, finasteride, cimetidine, risperidone.

When to See a GP About Breast Tissue Changes

Men should see a GP promptly for any firm, unilateral, or rapidly growing breast lump; those aged 50 or over with a unilateral subareolar mass should be referred urgently via the two-week-wait pathway to exclude male breast cancer.

Many men feel embarrassed or uncertain about seeking medical advice for breast tissue changes, but it is important to have any new or unexplained changes assessed by a GP. Gynaecomastia is usually benign, but some symptoms warrant prompt medical attention to rule out more serious underlying conditions.

You should contact your GP if you notice:

• A firm or rubbery lump beneath one or both nipples

• Breast swelling that is tender or painful

• Nipple discharge of any kind

• Asymmetrical breast enlargement, particularly if only one side is affected

• Rapid or progressive growth of breast tissue

• Skin changes over the breast, such as dimpling, redness, or skin tethering

• Nipple inversion or retraction

• A hard, fixed mass, or swelling of the lymph nodes in the armpit

In line with NICE guidance (NG12: Suspected cancer: recognition and referral), men aged 50 or over with a unilateral, firm subareolar mass — with or without nipple discharge — should be referred urgently via the two-week-wait pathway to exclude male breast cancer. While male breast cancer is rare — accounting for less than 1% of all breast cancer cases in the UK — it is not impossible, and any persistent unilateral lump should be evaluated without delay.

You should also seek prompt GP assessment if you notice a new testicular lump, swelling, or pain, as these may indicate a hormone-secreting tumour that could contribute to gynaecomastia.

It is also worth seeing a GP if you are concerned about a medication you are taking that may be contributing to breast tissue changes, or if you are experiencing other symptoms of hormonal imbalance such as reduced libido, erectile dysfunction, fatigue, or mood changes. Your GP can review your medication history, assess your alcohol intake, and arrange appropriate investigations. Early assessment not only provides reassurance but also ensures that any treatable underlying cause is identified and managed in a timely manner.

Sources: NICE NG12: Suspected cancer: recognition and referral; NHS: Male breast cancer; NHS: Gynaecomastia (enlarged male breasts).

Diagnosis and Treatment Options Available on the NHS

NHS assessment includes blood tests, hormone panels, and imaging; treatment ranges from addressing the underlying cause and stopping offending medications to specialist-initiated tamoxifen or surgical excision for persistent cases.

When a man presents to his GP with breast tissue changes, the assessment will typically begin with a detailed medical history, including alcohol consumption, current medications, recreational drug use, and any relevant family history. A physical examination will help distinguish true gynaecomastia from pseudogynaecomastia or other causes of breast swelling.

Investigations may include:

• Blood tests to assess hormone levels (testosterone, oestradiol, LH, FSH, prolactin), liver function, thyroid function, and renal function

• Serum human chorionic gonadotrophin (hCG), to screen for hCG-secreting tumours

• Testicular ultrasound if a hormone-secreting tumour is suspected

• Breast ultrasound as the first-line imaging investigation for a palpable mass in men; mammography may be considered based on age and clinical suspicion

• Karyotype testing if clinical features suggest Klinefelter syndrome

In many cases, gynaecomastia resolves on its own — particularly in adolescents or when an offending medication is stopped. If alcohol is identified as a contributing factor, reducing or stopping alcohol intake may lead to gradual improvement, especially if liver function recovers. Do not stop any prescribed medicine without first discussing this with your GP.

For persistent or symptomatic gynaecomastia, treatment options available through the NHS include:

• Medical management: Tamoxifen (an oestrogen receptor modulator) may be used off-label in some cases and is typically initiated by a specialist rather than in primary care. Aromatase inhibitors have been used in this context but evidence supporting their routine use is limited, and they are not currently recommended as standard treatment. NICE does not have specific guidance on pharmacological treatment for gynaecomastia in adults.

• Surgical treatment: Liposuction or glandular tissue excision may be considered for longstanding or significant gynaecomastia that causes psychological distress. Access to surgery on the NHS varies by locality and is subject to the policies of local integrated care boards (ICBs) and NHS England's Evidence-Based Interventions programme.

Referral to an endocrinologist, breast surgeon, or urologist may be arranged depending on the suspected underlying cause. The goal of treatment is always to address the root cause where possible, rather than simply managing the symptom.

Sources: NICE CKS: Gynaecomastia; BNF: Tamoxifen; MHRA/EMC SmPC: Tamoxifen.

Reducing Alcohol Intake and Managing Gynaecomastia

Reducing or stopping alcohol is the most important step when it is a contributing factor, as hormonal disruption is often reversible; UK guidelines recommend no more than 14 units per week with several drink-free days.

If alcohol is identified as a contributing factor to gynaecomastia, reducing or stopping alcohol consumption is one of the most important steps a man can take. The hormonal disruption caused by alcohol is often partially or fully reversible, particularly if liver disease has not yet become advanced. Testosterone levels may begin to recover within weeks to months of abstinence, and oestrogen metabolism can improve as liver function is restored.

Practical steps to reduce alcohol intake include:

• Keeping within the UK Chief Medical Officers' low-risk drinking guideline of no more than 14 units per week, spread across three or more days, with several drink-free days each week

• Keeping a drink diary to monitor consumption honestly

• Replacing alcoholic drinks with lower-alcohol or alcohol-free alternatives

• Seeking support from a GP, who can refer to local alcohol support services or recommend structured programmes

Organisations such as Alcohol Change UK and the NHS alcohol support services offer accessible resources and behaviour change tools for those looking to cut down. For men with alcohol dependence, medically supervised withdrawal may be necessary — stopping suddenly without medical guidance can be dangerous and should always be discussed with a healthcare professional first.

Alongside reducing alcohol, maintaining a healthy weight through balanced nutrition and regular physical activity can help reduce aromatase activity and support overall metabolic health. Resistance exercise may support body composition and general wellbeing; while some studies suggest modest effects on testosterone, sustained increases in baseline testosterone levels from exercise alone are inconsistent and should not be overstated.

Managing gynaecomastia is rarely a single-step process. It often requires addressing multiple contributing factors simultaneously — whether that is alcohol, medication, weight, or an underlying medical condition. With appropriate support and lifestyle changes, many men see meaningful improvement over time, and the psychological impact of the condition should never be underestimated when seeking help.

Sources: UK Chief Medical Officers' low risk drinking guidelines; NHS: Alcohol support services; Alcohol Change UK.

Frequently Asked Questions